Vitruvias Therapeutics
Dr. Katie Carroll joined Vitruvias Therapeutics in April of 2019 as the Director of Regulatory Affairs and Pharmacovigilance. Prior to joining Vitruvias, Katie served as the Associate Director of Regulatory Affairs and Pharmacovigilance for Kowa Pharmaceuticals America, Inc. in Montgomery, AL.
This person is not in the org chart
Vitruvias Therapeutics
Vitruvias is a specialty generic pharmaceutical business focused on the development and marketing of generic products with either (i) complex APIs that are difficult to source, or (ii) finished dosage forms that are inherently difficult to manufacture.